Related Experiment Video
Updated: Aug 10, 2026
Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
Informed consent and anonymous tissue samples: the case of HIV seroprevalence studies
1Department of Medical Humanities, School of Medicine, East Carolina University, Greenville, NC 27858-4354, USA.
Insights
Human Immunodeficiency Virus (HIV) seroprevalence studies often use anonymous tissue samples without donor consent. This practice requires careful ethical consideration and regulation, not automatic exemption from informed consent requirements.
Area of Science:
- Medical Ethics
- Public Health Research
- Biomedical Research
Background:
- Anonymous tissue samples are frequently utilized in Human Immunodeficiency Virus (HIV) seroprevalence studies.
- Current practices often involve obtaining these samples from hospitals and clinics without explicit donor consent.
Purpose of the Study:
- To critically evaluate the ethical implications of using anonymous tissue samples in HIV seroprevalence studies without donor consent.
- To propose recommendations for the ethical conduct of research involving anonymous tissue samples, particularly concerning informed consent.
Main Methods:
- Analysis of current practices in HIV seroprevalence studies regarding tissue sample consent.
- Discussion of ethical justifications for waiving consent in public health emergencies.
- Formulation of recommendations based on ethical consensus and regulatory needs.
Main Results:
- Waiver of consent for anonymous tissue samples in HIV studies should not be a default practice, even in public health emergencies.
- Studies should be individually assessed for the necessity and extent of consent modification or omission.
- There is a recognized need for enhanced regulation governing the research use of tissue samples.
Conclusions:
- Informed consent principles should be upheld to the greatest extent possible when using anonymous tissue samples.
- Investigators must provide clear justification for waiving or modifying consent, and institutional review boards must rigorously evaluate these requests.
- Strengthening regulatory frameworks is crucial for the ethical governance of tissue sample research.
Abstract:
Human Immunodeficiency Virus (HIV) seroprevalence studies use anonymous tissue samples obtained in hospitals and clinics without donor consent. This can be justified as a response to a public health emergency, but should not be seen as setting a precedent for waiving consent whenever samples are anonymous. The following recommendations grow out of this discussion: (1) Studies using anonymous tissue samples should not be automatically exempt from consent requirements, and consent should not be waived simply to avoid anticipated refusals, low participation rates or self selection bias. (2) The consensus on informed consent favors fulfilling as many of the elements of informed consent as reasonably possible, so studies should be assessed individually to determine if any or all elements of informed consent should be modified or omitted. (3) There is a need for greater regulation of the research use of tissue samples. (4) Investigators seeking approval to waive consent or modify elements of informed consent should document the sort of new findings that they believe would effect their calculations about the benefits and burdens to subjects who are enrolled in the study, and institutional review boards should indicate whether they agree with the investigators' analysis.
